3 Results
Guidelines and Advice
Status: Current
ID: GL-1-A-2016-2
ID: GL-1-A-2016-2
Oct 2017
Drug
Jan 2022
Guidelines and Advice
Status: Current
ID: GL 2-33
ID: GL 2-33
Jun 2022